JNJ logo Johnson & Johnson +
Johnson & Johnson
+

Johnson & Johnson Overview

Company: Johnson & Johnson
CEO: Joaquin Duato
Founded: Jan 1, 1886
Symbol: JNJ
Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutionsluding electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Continue reading...

Johnson & Johnson (JNJ)

  • Stock Price
  • Volume
213.65 +53.00 +32.99%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Johnson & Johnson annual revenue was $88.82 B in 2024.

Net Income

Johnson & Johnson annual net income was $14.07 B in 2024.

Employees

Johnson & Johnson annual employee count was 138,100 in 2025.

Revenue by Segment

Johnson & Johnson’s revenue by segment: Innovative Medicine: $56.96 B and MedTech: $31.86 B in 2024.

Revenue by Region

Johnson & Johnson’s revenue by region: Asia-Pacific, Africa: $13.59 B, Europe: $20.21 B, UNITED STATES: $50.30 B and Western Hemisphere, excluding U.S.: $4.71 B in 2024.

Executive Salary

J. Duato Chairman/CEO, at Johnson & Johnson, makes $24.30 M in total...

Revenue per Employee

Johnson & Johnson revenue per employee was - in 2025.

Profit per Employee

Johnson & Johnson profit per employee was - in 2025.

Income Statement

Operating Income

Johnson & Johnson annual operating income was $22.15 B in 2024.

Research & Development

Johnson & Johnson annual research & development expense was $17.23 B in 2024.

Tax Rate (%)

Johnson & Johnson annual Tax Rate was 16.00% in 2024.

Assets & Liabilities | Cash Flow

Total Assets

Johnson & Johnson annual total assets was $180.10 B in 2024.

Total Liabilities

Johnson & Johnson annual total liabilities was $108.61 B in 2024.

Capital Expenditure

Johnson & Johnson annual capital expenditures was -$4.42 B in 2024.

Ratios

Return on Equity (ROE)

Johnson & Johnson annual return on equity(ROE) was 19.68% in 2024.

Return on Assets (ROA)

Johnson & Johnson annual return on assets(ROA) was 7.81% in 2024.

Debt to Equity

Johnson & Johnson annual debt to equity was 52.92% in 2024.

Profitability

Gross Profit Margin (%)

Johnson & Johnson annual gross profit margin was 69.07% in 2024.

Operating Income Margin (%)

Johnson & Johnson annual operating income margin was 24.94% in 2024.

Net Income Margin (%)

Johnson & Johnson annual net income margin was 15.84% in 2024.

Earning Per Share

Johnson & Johnson annual earning per share was $5.84 in 2024.

EBITDA

Johnson & Johnson annual EBITDA was $24.78 B in 2024.

Free Cash Flow (FCF)

Johnson & Johnson annual free cash flow(FCF) was $19.84 B in 2024.

Valuation

Enterprise value

Johnson & Johnson annual enterprise value was $358.79 B in 2024.

Enterprise value to Revenue

Johnson & Johnson annual enterprise value to revenue was 4.04 in 2024.

Enterprise value to EBITDA

Johnson & Johnson annual enterprise value to EBITDA was 14.48 in 2024.

Competitors’ Revenue

Frequently Asked Questions

When was Johnson & Johnson founded?

Johnson & Johnson was founded on Jan 1, 1886, which makes the company 140 years old.

Sign up for free to view

Who is the CEO of Johnson & Johnson?

Joaquin Duato is the CEO of Johnson & Johnson.

What industry and sector is Johnson & Johnson in?

Johnson & Johnson operates in the Drug Manufacturers - General industry and the Healthcare sector.

What are Johnson & Johnson's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000200406
  • SIC (Standard Industrial Classification): 2834
  • ISIN (International Securities Identification Number): US4781601046

Sign up for free to view

How many employees does Johnson & Johnson have?

Johnson & Johnson has 138,100 employees.

What is the revenue of Johnson & Johnson?

In fiscal year 2024, Johnson & Johnson generated a revenue of $88.82 Billion.

What is the net income of Johnson & Johnson?

In fiscal year 2024, Johnson & Johnson reported a net income of $14.07 Billion.

What is Johnson & Johnson's biggest product segment?

Innovative Medicine is Johnson & Johnson's biggest product segment, representing 64.13% of its total revenue.

When was Johnson & Johnson listed on the stock exchange?

Johnson & Johnson went public on Jan 2, 1943, through its Initial Public Offering (IPO), and it has been 83 years since then.

Sign up for free to view

What is the ticker symbol of Johnson & Johnson, and where is it listed?

Johnson & Johnson's ticker symbol is JNJ, and the company is listed on the NYSE stock market exchange.

What is Johnson & Johnson's current stock price?

Johnson & Johnson's current stock price is $213.67 as of Jan 14, 2026.

What is Johnson & Johnson's market capitalization?

As of , Johnson & Johnson's market cap is .

What is Johnson & Johnson's ranking in the world?

Ranked #2among 2,854 companies based on market cap.

Who are the top competitors of Johnson & Johnson?

Competitors of Johnson & Johnson include Eli Lilly and Company, AbbVie and Merck & Co., and more.

Related company

Submit feedback to Bullfincher